Atara Biotherapeutics logo
Atara Biotherapeutics ATRA
€ 7.95 -3.15%

Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024

report update icon

Atara Biotherapeutics Kennzahlen 2011-2025 | ATRA

Kennzahlen Jährlich Atara Biotherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.3 -2.3 -4.3 -4.7 -2.4 -6.9 -10.1 -4.6 -8.1 -4.3 - - -

P/S

8.5 8.2 - - - - - - - - - - -

EPS

-2.6 -2.2 -3.6 -4.2 -5.7 -5.3 -4 -2.8 - - - - -

EV (Enterprise Value)

312 M 676 M 1.56 B 1.38 B 676 M 1.58 B 1.16 B 326 M 449 M 102 M 11.2 M 3.81 M -

EBITDA per Share

-2.56 -2.69 -3.53 -4.07 -5.63 -5.33 -4.04 -2.81 -2.28 -5.65 - - -

EV/EBITDA

-4.5 -3.9 -2.2 -6.5 -9.3 -3.9 -7.5 -3.5 - - -

PEG

0.02 0.42 -0.54 -0.31 0.32 0.22 0.22 0.2 -0.13 0.01 - - -

P/B

-0.7 4.1 5.3 3.1 2.4 4.7 6.8 1.4 1.5 1.2 - - -

P/CF

-0.4 -1.9 -6.7 -8.0 -2.9 -7.3 -11.2 -5.8 -12.4 -7.3 - - -

ROE %

278.27 -180.28 -121.65 -66.32 -100.07 -68.08 -67.18 -31.15 -18.16 -27.14 - - -

ROA %

-166.84 -60.65 -72.66 -52.14 -84.85 -58.88 -54.87 -29.95 -17.61 -26.39 - - -

ROCE %

278.14 -221.50 -121.76 -66.85 -96.56 -67.39 -63.92 -31.95 -18.54 -27.23 - - -

Current Ratio

0.6 1.5 2.5 4.7 7.4 8.0 6.2 26.9 33.4 38.9 - - -

DSO

1582.3 118.3 - - - - - - - - - - -

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Betriebszyklus

1582.3 118.3 - - - - - - - - - - -

Finanzkreislauf

1582.3 118.3 - - - - - - - - - - -
P/E
P/S
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202320232022202220212021202020202019201920182018201720172016201620152015201420142013201320122012201120112000 2000 1500 1500 1000 1000 500 500 0 0 -500 -500
Download SVG
Download PNG
Download CSV

Alle Zahlen in USD-Währung

Kennzahlen Vierteljährlich Atara Biotherapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-2.93 -3.1 -0.23 - -16.4 -16.91 -0.72 - -0.82 0.18 -0.87 - -0.9 -0.91 -0.86 - -0.92 -1.14 -1.2 - -1.31 -1.6 -1.44 - -1.29 -1.15 -1.05 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

-2.83 -2.85 -0.21 - -16.1 -16.8 -0.71 - -0.82 -0.3 -0.86 - -0.88 -0.89 -0.83 - -0.89 -1.12 -1.19 - -1.29 -1.59 -1.44 - -1.3 -1.17 -1.06 - -1.03 -0.95 -0.89 - -0.9 -0.68 -0.6 - -0.44 -0.62 -0.42 - - -3.39 -5.6 - -2.61 - - -5.58 - - - - - - -

ROE %

210.97 324.07 -647.07 -931.77 -976.71 -1158.94 -197.81 -77.05 -104.35 -86.70 -119.15 -72.20 -88.28 -77.07 -68.55 -48.73 -73.46 -82.10 -90.91 -73.07 -90.30 -82.79 -72.25 -44.47 -61.95 -62.21 -62.62 -47.33 -57.33 -49.84 -41.86 -23.97 -27.73 -21.50 -18.80 -11.42 -17.15 -19.12 -18.75 -16.94 6.08 34.83 39.21 133.30 243.57 220.55 110.28 110.28 - - - - - - -

ROA %

-87.78 -109.40 -122.01 -90.58 -113.41 -99.27 -66.18 -40.77 -59.59 -55.58 -78.16 -51.95 -64.59 -58.42 -53.24 -38.31 -59.27 -67.60 -76.10 -61.96 -76.85 -70.78 -62.09 -38.46 -52.74 -52.12 -51.73 -38.65 -48.27 -43.60 -38.16 -23.04 -26.70 -20.73 -18.18 -11.07 -16.65 -18.57 -18.22 -16.47 -21.36 -20.68 -16.43 -4.89 -4.89 - - - - - - - - - -

ROCE %

- - - - -45.23 -90.45 -102.93 -97.03 -124.38 -106.50 -119.36 -72.29 -88.45 -77.26 -68.79 -49.17 -74.13 -82.92 -92.04 -74.28 -91.40 -83.57 -72.55 -44.15 -60.80 -60.33 -60.05 -45.09 -55.29 -48.85 -41.83 -24.58 -28.47 -22.15 -19.28 -11.63 -17.40 -19.28 -18.88 -17.02 6.15 35.08 39.47 132.98 242.80 219.64 109.82 109.82 - - - - - - -

Current Ratio

0.6 0.5 0.6 0.6 0.8 1.0 1.3 1.5 2.0 2.4 2.3 2.5 3.2 3.6 4.1 4.7 4.7 4.7 4.7 6.6 6.6 6.6 6.6 7.4 7.4 7.4 7.4 5.5 5.5 5.5 5.5 25.9 25.9 25.9 25.9 32.9 32.9 32.9 32.9 36.1 36.1 36.1 36.1 29.6 29.6 - - - - - - - - - -

DSO

4.3 60.9 116.7 - 14.3 43.1 1511.6 - 9.1 1.1 10.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Betriebszyklus

4.3 60.9 116.7 - 14.3 43.1 1511.6 - 9.1 1.1 10.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Finanzkreislauf

4.3 60.9 116.7 - 14.3 43.1 1511.6 - 9.1 1.1 10.3 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
P/E
P/S
EPS
EV/EBITDA
PEG
P/B
P/CF
ROE %
ROA %
ROCE %
Current Ratio
DSO
DIO
DPO
202320232022202220212021202020202019201920182018201720172016201620152015201420142013201320122012201120112000 2000 1500 1500 1000 1000 500 500 0 0 -500 -500
Download SVG
Download PNG
Download CSV

Alle Zahlen in USD-Währung